Prostate screening uptake in Australian BRCA1 and BRCA2 carriers

Men who carry mutations in BRCA1 or BRCA2 are at increased risk for prostate cancer. However the efficacy of prostate screening in this setting is uncertain and limited data exists on the uptake of prostate screening by mutation carriers. This study prospectively evaluated uptake of prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: McKinley, Joanne M, Weideman, Prue C, Jenkins, Mark A, Friedlander, Michael L, Hopper, John L, McLachlan, Sue-Anne, Lindeman, Geoffrey J, Investigators, kConFab, Phillips, Kelly-Anne
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736989/
https://www.ncbi.nlm.nih.gov/pubmed/19725993
http://dx.doi.org/10.1186/1897-4287-5-3-161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736989/
https://www.ncbi.nlm.nih.gov/pubmed/19725993
http://dx.doi.org/10.1186/1897-4287-5-3-161

Ejemplares similares